Cite
Gentile D, Fornai M, Pellegrini C, et al. Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity. Front Pharmacol. 2018;9:1094doi: 10.3389/fphar.2018.01094.
Gentile, D., Fornai, M., Pellegrini, C., Colucci, R., Benvenuti, L., Duranti, E., Masi, S., Carpi, S., Nieri, P., Nericcio, A., Garelli, F., Virdis, A., Pistelli, L., Blandizzi, C., & Antonioli, L. (2018). Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity. Frontiers in pharmacology, 91094. https://doi.org/10.3389/fphar.2018.01094
Gentile, Daniela, et al. "Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity." Frontiers in pharmacology vol. 9 (2018): 1094. doi: https://doi.org/10.3389/fphar.2018.01094
Gentile D, Fornai M, Pellegrini C, Colucci R, Benvenuti L, Duranti E, Masi S, Carpi S, Nieri P, Nericcio A, Garelli F, Virdis A, Pistelli L, Blandizzi C, Antonioli L. Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity. Front Pharmacol. 2018 Sep 25;9:1094. doi: 10.3389/fphar.2018.01094. eCollection 2018. PMID: 30319424; PMCID: PMC6167518.
Copy
Download .nbib